LINDIS Biotech Receives Positive CHMP Opinion for KORJUNY(R) (catumaxomab) in the European Union
Upon authorization by the European Commission, KORJUNY® will be the only drug approved and available for the intraperitoneal treatment of malignant ascites in adults with epithelial cell adhesion ...
Le Lézard1h
Okomera Gets ?1.5 Million Grant to Develop Microfluidics & AI Powered CRISPR Editing Platform for Target Validation
Okomera announces Bpifrance funding to develop and standardize novel CRISPR screening assay to accelerate drug discovery in oncology with leading cancer research center of Marseille, CRCM. Okomera is ...
Okomera Gets €1.5 Million Grant to Develop Microfluidics & AI Powered CRISPR Editing Platform for Target Validation
Okomera announces Bpifrance funding to develop and standardize novel CRISPR screening assay to accelerate drug discovery in ...
ASP Isotopes Up On Radiopharmaceutical And Nuclear Fuel Demand
ASP Isotopes has proprietary technology and a favorable demand backdrop in two sectors that make the company worth ...
Exploring High Growth Tech Stocks In Hong Kong
As global markets experience shifts with interest rate adjustments and economic indicators showing mixed signals, the Hong Kong market remains a focal point for investors seeking opportunities in high ...